Harun Ali

Harun Ali supports critical procurement activities at the National Institute of Allergy and Infectious Diseases (NIAID), facilitating acquisitions that advance biomedical research to combat infectious, immunologic, and allergic diseases. While his formal title is not specified, his role centers on managing contract actions aligned with NIAID’s mission to accelerate the development of medical countermeasures, diagnostic platforms, and high-containment laboratory infrastructure. He routinely handles research and development contracts requiring specialized scientific expertise, particularly in biosafety, biocontainment, and infectious disease diagnostics, ensuring timely delivery of mission-critical capabilities to respond to emerging public health threats. Ali maintains a focused contractor network, primarily partnering with Quality Biological, Inc., a key supplier of biological reference materials and research reagents, and GENOMIC LABS LTD, a provider of genomic sequencing and analysis services. These relationships reflect a preference for specialized vendors with proven technical capabilities in bioscience supply chains and high-complexity research support. His contracting patterns indicate long-term, mission-aligned vendor partnerships rather than broad, open-market solicitations, suggesting a strategic emphasis on reliability, regulatory compliance, and scientific rigor. Ali’s procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a mission-driven prioritization of technical capability and scientific merit over socioeconomic criteria, consistent with NIAID’s need for rapid, high-quality delivery of specialized research tools and biological materials under stringent biosafety standards. His primary NAICS classification is 541714—Research and Development in Biotechnology—indicating deep specialization in procuring advanced biotech R&D services, including recombinant protein production, pathogen characterization, assay development, and biosafety-level 3/4 laboratory support. His work directly enables cutting-edge research in vaccine development, diagnostic innovation, and pathogen surveillance, requiring contractors with expertise in GMP-grade production, biospecimen handling, and regulatory-compliant data generation.